Back to Results
First PageMeta Content
Health / Cyproterone / Bayer HealthCare Pharmaceuticals / Combined oral contraceptive pill / Oral contraceptive formulations / Acne vulgaris / Estrogen / Clinical trial / Desogestrel / Hormonal contraception / Endocrine system / Medicine


Drug regulatory failure in Canada The case of Diane-35 by Barbara Mintzes Women and Health Protection, October[removed]Abstract
Add to Reading List

Document Date: 2010-06-08 19:24:32

Open Document

File Size: 70,83 KB

Share Result on Facebook

Company

Canada Health Canada / CBC / Medline / Berlex / Health Canada / Schering / /

Continent

Europe / /

Country

Germany / New Zealand / Malaysia / Canada / Australia / United Kingdom / /

Event

FDA Phase / /

Facility

Cochrane Library of Systematic Reviews / /

IndustryTerm

media criticism / comparison / treatment for prostate cancer / prescription drug advertising / cancer-causing chemical / estrogen-progestin combination products / higher estrogen dose product / combination product / literature search / chemical / /

MedicalCondition

pus / acne cysts / potential cancer / back acne / blood clots / liver disorders / milder acne / hirsutism / fewer acne / unsuccessful acne / prostate cancer / birth defects / precocious puberty / mild acne / cancer / acne / disease / fatal blood clots / severe / untreatable acne / severe acne / deep vein thrombosis / liver cancer / polycystic ovary syndrome / pulmonary emboli / facial acne / venous thromboembolism / woman’s acne / polycystic ovary disease / /

MedicalTreatment

oral contraceptives / birth control / antibiotics / /

Organization

World Health Organization / Canadian government / US Food and Drug Administration / FDA / /

Person

Walter Spitzer / Mario Pini / /

Position

editor / first author / author / /

Product

Ovral / Min-Ovral / Marvelon / levonorgestrel / estradiol / Canada / 13 / acne / 16 / Canada / Diane-35 / /

Technology

pharmacokinetics / /

SocialTag